Advanced search×
×

All Therapeutics Combined Modality Therapy Chemotherapy, Adjuvant

Chemotherapy, Adjuvant 2,735 articles


  1. Risk of sinonasal-cutaneous fistula after treatment for advanced sinonasal cancer.

    Journal of Surgical Oncology 105(3):261 (2012) PMID 22375288

    To determine the rate and the risk factors for sinonasal-cutaneous fistula formation after treatment for sinonasal malignancy. Between 1991 and 2002, 99 patients with advanced sinonasal malignancy received radiation therapy +/- surgery. Primary site was maxillary sinu...
  2. Neo-adjuvant chemotherapy and radical surgery for stage 1B cervical cancer in pregnancy.

    Journal of Obstetrics & Gynaecology 32(2):191 (2012) PMID 22296440

  3. Is neo-adjuvant chemotherapy a "waiver" of extensive upper abdominal surgery in advanced epithelial ovarian cancer?

    Annals of Surgical Oncology 18(13):3824 (2011) PMID 21691879

    We analyzed the surgical outcomes and frequency of extensive procedures required for maximal cytoreductive surgery after NAC and primary debulking surgery (PDS) in 256 women with advanced epithelial ovarian cancer. NAC was performed in 116 of 256 women (45.3%). In NAC group, complete...
  4. Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer s...

    Journal of Clinical Oncology 29(6):719 (2011) PMID 21205748

    We could not identify any factors predicting relapse in CS1 patients who were subjected to surveillance only. In CS2A, 10.9% (three of 29) patients relapsed after radiotherapy compared with no relapses in CS2A/B patients (zero of 73) treated with chemotherapy (P = .011). An internati...
  5. Gene expression profiling of response to mTOR inhibitor everolimus in pre-operatively treated post-menopausal women with oestrogen receptor-...

    Breast Cancer Research and Treatment 122(2):419 (2010) PMID 20480226

    There is growing evidence that uncontrolled activation of the PI3K/Akt/mTOR pathway contributes to the development and progression of breast cancer. Inhibition of this pathway has antitumour effects in preclinical studies and efficacy in combination with other agents in breast cancer...
  6. [Adjuvant chemotherapy of adults soft tissue sarcomas].

    Bulletin du cancer 97(6):673 (2010) PMID 20547481

    The main progress in the management of soft tissue sarcomas have been obtained in the field of local control. Although the main evolutive, vital, risk of these diseases is metastatic dissemination, efficacy of adjuvant chemotherapy remains a controversial issue. Thus, adjuvant chemotherapy cannot be...
  7. [Cardiotoxicity in performing chemotherapy of breast cancer by the data of retrospective multicenter "case-control" investigation].

    Vestnik khirurgii imeni I. I. Grekova 169(4):17 (2010) PMID 20973179

    The authors describe results of 5 year observations of the state of the cardiovascular system in 1643 women who underwent nonajuvant and adjuvant polychemotherapy of breast cancer within the framework of retrospective multicenter case-control investigation. The total frequency of registration of acu...
  8. Analysis of the effect of radiotherapy on malignant pleural mesothelioma when given on adjuvant or palliative basis.

    Chinese Journal of Lung Cancer 13(1):54 (2010) PMID 20672705

    This retrospective study was designed to evaluate the response and survival of malignant pleural mesothelioma to radiotherapy when delivered with surgery and chemotherapy and when delivered alone or with chemotherapy. A study for 110 patients with malignant pleural me...
  9. [Breast cancer metastasis in distal phalanx of the big toe. Case report].

    Il Giornale di chirurgia 30(11-12):487 (2009) PMID 20109377

    We present a rare case of 47-year-old woman, who underwent to monolateral mastectomy for lobular cancer. After 8 years from surgery, she presented pain, swelling and functional limitations, gradually increasing, to the left big toe. X-rays and MRI showed a lucent area of bone destruction on the shaf...
  10. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007.

    Annals of Oncology 18(7):1133 (2007) PMID 17675394

    The 10th St Gallen (Switzerland) expert consensus meeting in March 2007 refined and extended a target-oriented approach to adjuvant systemic therapy of early breast cancer. Target definition is inextricably intertwined with the availability of target-specific therapeutic agents. Sinc...